Madison, Wisconsin, USA
November 3, 2022

DNASTAR® announced today the release of Lasergene® 17.4, which includes significant new functionality focused on variant analysis for multiple sequence alignments. The new version of Lasergene also incorporates several updates to the sequence editing and sequence assembly applications offered by DNASTAR.

While DNASTAR has long provided a strong variant analysis offering for sequence assembly data, this release includes the new ability to compute and analyze variants for multiple sequence alignments including viral, mitochondrial and chloroplast genomic sequences. Reference sequences can now be designated for all alignment algorithms to compute variants. Details about each detected variant in the alignment, including position, feature, impact, and translation changes, can be analyzed and evaluated in a new tabular view. This new functionality is available in MegAlign Pro, part of the Lasergene Molecular Biology package.

A full list of enhancements and updates can be found in the Lasergene 17.4 release notes.

Shawn Grass, General Manager at DNASTAR, said, “We are excited to bring this new variant analysis functionality to our customers, many of whom have requested this feature. We believe that the ability to view translation changes that result from a variant in a particular genome will be particularly powerful.”
About DNASTAR

DNASTAR, Inc., Madison, Wisconsin, (www.dnastar.com) is a pioneer in the development and sale of software used to increase life scientists’ productivity using their desktop computer or on the Amazon Cloud. DNASTAR Lasergene supports molecular biologists, geneticists, and structural biologists in meeting virtually all of their DNA, RNA, and protein sequence needs, including Sanger and next-generation sequence assembly and analysis, protein sequence and structure analysis, protein structure prediction, antibody modeling, and protein-protein docking with easy-to-use, affordable, flexible computer software.

Website: http://www.dnastar.com

Published: November 3, 2022